Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
Glycoprotein IIb/IIIa inhibitors (GPI) are an adjuvant therapy for the treatment of patients with acute coronary syndromes before, during and after percutaneous coronary intervention (PCI).1 The main adverse reactions are bleeding and thrombocytopenia in 1 –2% of cases, the latter being a rare presentation but with potential catastrophic consequences. Although the pathogenesis of this phenome...
Source: Radcliffe Cardiology - Category: Cardiology Authors: c242508f1d9059bc0f2aa9bdd5421ba2 Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Thrombocytopenia